Allurion Technologies (NYSE: ALUR) shares are moving higher Friday potentially after after the company announced plans to conduct a clinical study evaluating the combination of its Allurion Program with GLP-1 agonists on Thursday.
Allurion Technologies Shares Are Up Today: What’s Going On?
